Drug for treating insomnia

Abstract

The invention relates to a drug for treating insomnia. The drug is prepared from the following materials in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of coptis chinensis, 5-15 parts of chrysanthemum, 10-30 parts of woundwort, 1-15 parts of henbane, 10-20 parts of ephedra, 15-30 parts of pyrrosia lingua, 20-30 parts of hawthorn, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of lalang grass rhizome, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of kaladana, 15-20 parts of herba inulae, 15-30 parts of glabrous sarcandra herb, 10-20 parts of polygala tenuifolia, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of rhododendron dauricum, 15-25 parts of potentilla discolor, 10-20 parts of smoked plum, 15-25 parts of folium artemisiae argyi, 20-30 parts of lindley eupatorium, 1-20 parts of horsetail and 10-25 parts of chinese azalea flower. All the components of the drug for treating insomnia in the invention are natural materials, so the drug is good in safety, clear in curative effect and suitable for large-scale promotion clinically.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a medicament for treating insomnia. Background technique [0002] Insomnia is a common and frequently-occurring disease in clinical practice. Once it occurs, it will have a great negative impact on the daily work and life of the patient. Modern medicine usually uses common sedative drugs in the treatment of insomnia, but for some intractable insomnia, because there are many interference factors, the curative effect of using common sedative drugs is often not ideal, and most of these sedative drugs are likely to cause many complications. Adverse reactions, long-term use will lead to dependence, drug resistance, and side effects such as damage to liver and kidney functions. Therefore, ordinary sedative drugs should not be taken for a long time. Currently, there is an increasing demand for drugs for the treatment of insomnia. Contents of the invention [0003] The object of the present i...

AI Technical Summary

Problems solved by technology

Modern medicine usually uses common sedative drugs in the treatment of insomnia, but for some intractable insomnia, because there are many interference factors, the curative effect of using common sedative drugs is often not ideal, and most of these sedative drugs are likely to cause many complications. Adverse reactions, long-term use will lead to dependence, drug resistance, and side effects such as damage to liver and kidney functions. Therefore, ordinary sedative drugs should not be taken for a long time